Satoren Brandon purchased $2K of MLCI

Mount Logan Capital (MLCI) reported Q2 2026 earnings with segment income rising to $4.3M from $3.3M in Q1, and net loss improving to $4.2M from $6M. Total revenue was $8.7M, with assets under management at $2.0B. The company expects $2.8M in annual fee-related earnings from the Yieldstreet acquisition, set to close in Q3. Management highlighted growth initiatives and risk factors, including volatility in spread-related earnings from the long-term care book.

Mount Logan Capital (MLCI) reported Q2 2026 Segment Income of $4.3M, up $2.1M YoY, driven by Insurance Solutions. Consolidated net loss before taxes was $4.2M and basic loss per share was $0.37. Total revenues were $8.7M vs $17.1M a year earlier. The Ability unit received a B+ AM Best rating and a SOFIX deal to buy Yieldstreet assets is pending for Q3 2026.

Mount Logan Capital Inc. (MLCI) filed an SEC Form 8-K — Results of Operations and Financial Condition. FOR IMMEDIATE RELEASE Mount Logan Capital Inc. Announces Second Quarter 2026 Financial Results Segment Income for the quarter improved to $4.3 million, an increase of $2.1 million year-over-year, and $1.0 million as compared to first quarter 2026 Strong quarter for Insurance Solu

DE ANGOITIA ALFONSO purchased 476,190 indirectly-held shares of Liberty Latin America Ltd. (LILA) at an average of $20.95 ($20.65–$21.00, $9.98M total) across 3 trades over 2026-08-31 to 2026-09-02.

Meister Keith A. sold 263,560 indirectly-held shares of ILLUMINA, INC. (ILMN) at an average of $217.03 ($213.20–$221.55, $57.20M total) across 12 trades over 2026-09-02 to 2026-09-04.

Spetzler David Baxley (President) sold 597,212 shares of Caris Life Sciences, Inc. (CAI) at an average of $24.84 ($24.76–$25.32, $14.83M total) across 3 trades over 2026-09-03 to 2026-09-04.